Weight Gain  >>  Korlym (mifepristone)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Korlym (mifepristone) / Corcept Therap
NCT00455442: A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain

Completed
2
57
RoW
Mifepristone
Corcept Therapeutics, Eli Lilly and Company
Weight-Gain Prevention
 
07/07

Download Options